BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cornberg M, Buti M, Eberhardt CS, Grossi PA, Shouval D. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients. J Hepatol. 2021;74:944-951. [PMID: 33563499 DOI: 10.1016/j.jhep.2021.01.032] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 26.0] [Reference Citation Analysis]
Number Citing Articles
1 Piedade J, Pereira G. COVID-19 in liver transplant recipients. Journal of Liver Transplantation 2021;3:100026. [DOI: 10.1016/j.liver.2021.100026] [Reference Citation Analysis]
2 Nasa P, Alexander G. COVID-19 and the liver: What do we know so far? World J Hepatol 2021; 13(5): 522-532 [PMID: 34131467 DOI: 10.4254/wjh.v13.i5.522] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Agrawal D, Saigal S. Utilization of SARS-COV-2 positive donors and recipients for Liver transplantation in the pandemic era – An evidence-based review. Journal of Liver Transplantation 2022. [DOI: 10.1016/j.liver.2022.100081] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Rabinowich L, Grupper A, Baruch R, Ben-Yehoyada M, Halperin T, Turner D, Katchman E, Levi S, Houri I, Lubezky N, Shibolet O, Katchman H. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients. J Hepatol 2021;75:435-8. [PMID: 33892006 DOI: 10.1016/j.jhep.2021.04.020] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 37.0] [Reference Citation Analysis]
5 Toniutto P, Falleti E, Cmet S, Cussigh A, Veneto L, Bitetto D, Fornasiere E, Fumolo E, Fabris C, Sartor A, Peressutti R, Curcio F, Regattin L, Grillone L. Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.02.015] [Reference Citation Analysis]
6 Giannini EG, Marenco S. High acceptance rate of COVID-19 vaccination in liver transplant recipients. J Hepatol 2021;75:483-4. [PMID: 34052253 DOI: 10.1016/j.jhep.2021.05.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Madhu D, Sharma S, Agarwal A, Saraya A. Special Considerations in the Management of Autoimmune Hepatitis in COVID-19 Hotspots: A Review. J Clin Transl Hepatol 2021;9:568-75. [PMID: 34447687 DOI: 10.14218/JCTH.2021.00001] [Reference Citation Analysis]
8 Mohseni Afshar Z, Babazadeh A, Janbakhsh A, Mansouri F, Sio TT, Sullman MJM, Carson-Chahhoud K, Hosseinzadeh R, Barary M, Ebrahimpour S. Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities. Rev Med Virol 2021;:e2309. [PMID: 34677889 DOI: 10.1002/rmv.2309] [Reference Citation Analysis]
9 Wang J, Zhang Q, Ai J, Liu D, Liu C, Xiang H, Gu Y, Guo Y, Lv J, Huang Y, Liu Y, Xu D, Chen S, Li J, Li Q, Liang J, Bian L, Zhang Z, Guo X, Feng Y, Liu L, Zhang X, Zhang Y, Xie F, Jiang S, Qin W, Wang X, Rao W, Zhang Q, Tian Q, Zhu Y, Cong Q, Xu J, Hou Z, Zhang N, Zhang A, Zu H, Wang Y, Yan Z, Du X, Hou A, Yan Y, Qiu Y, Wu H, Hu S, Deng Y, Ji J, Yang J, Huang J, Zhao Z, Zou S, Ji H, Ge G, Zhong L, He S, Yan X, Yangzhen BB, Qu C, Zhang L, Yang S, Gao X, Lv M, Zhu Q, Xu X, Zeng Q, Qi X, Zhang W. Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study. Hepatol Int. [DOI: 10.1007/s12072-022-10332-9] [Reference Citation Analysis]
10 Wang X, Lei J, Li Z, Yan L. Potential Effects of Coronaviruses on the Liver: An Update. Front Med (Lausanne) 2021;8:651658. [PMID: 34646834 DOI: 10.3389/fmed.2021.651658] [Reference Citation Analysis]
11 Mann R, Sekhon S, Sekhon S. Drug-Induced Liver Injury After COVID-19 Vaccine. Cureus 2021;13:e16491. [PMID: 34430106 DOI: 10.7759/cureus.16491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chen LP, Zeng QH, Gong YF, Liang FL. Should people with chronic liver diseases be vaccinated against COVID-19? World J Clin Cases 2021; 9(26): 7959-7962 [PMID: 34621852 DOI: 10.12998/wjcc.v9.i26.7959] [Reference Citation Analysis]
13 Alukal JJ, Naqvi HA, Thuluvath PJ. Vaccination in Chronic Liver Disease: An Update. J Clin Exp Hepatol 2021. [PMID: 34975241 DOI: 10.1016/j.jceh.2021.12.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mikolasevic I, Bozic D, Pavić T, Ruzic A, Hauser G, Radic M, Radic-Kristo D, Razov-Radas M, Puljiz Z, Milic S. Liver disease in the era of COVID-19: Is the worst yet to come? World J Gastroenterol 2021; 27(36): 6039-6052 [PMID: 34629818 DOI: 10.3748/wjg.v27.i36.6039] [Reference Citation Analysis]
15 Reuken PA, Albers S, Rauchfuss F, Strnad P, Settmacher U, Trautwein C, Stallmach A, Bruns T. Acceptance of SARS-CoV-2 vaccines by liver transplant recipients and candidates. Z Gastroenterol 2021;59:1288-96. [PMID: 34670294 DOI: 10.1055/a-1649-8568] [Reference Citation Analysis]
16 Wang J, Hou Z, Liu J, Gu Y, Wu Y, Chen Z, Ji J, Diao S, Qiu Y, Zou S, Zhang A, Zhang N, Wang F, Li X, Wang Y, Liu X, Lv C, Chen S, Liu D, Ji X, Liu C, Ren T, Sun J, Zhao Z, Wu F, Li F, Wang R, Yan Y, Zhang S, Ge G, Shao J, Yang S, Liu C, Huang Y, Xu D, Li X, Ai J, He Q, Zheng MH, Zhang L, Xie Q, Rockey DC, Fallowfield JA, Zhang W, Qi X. Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study. J Hepatol 2021;75:439-41. [PMID: 33905793 DOI: 10.1016/j.jhep.2021.04.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Nasa P, Alexander G. COVID-19 and the liver: What do we know so far? World J Hepatol 2021;13:522-32. [PMID: 34131467 DOI: 10.4254/wjh.v13.i5.522] [Reference Citation Analysis]
18 Łykowska-Szuber L, Wołodźko K, Rychter AM, Szymczak-Tomczak A, Krela-Kaźmierczak I, Dobrowolska A. Liver Injury in Patients with Coronavirus Disease 2019 (COVID-19)-A Narrative Review. J Clin Med 2021;10:5048. [PMID: 34768568 DOI: 10.3390/jcm10215048] [Reference Citation Analysis]
19 Toniutto P, Aghemo A, Grossi P, Burra P; Permanent Transplant Commission of the Italian Association for the Study of the Liver. Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients. Dig Liver Dis 2021:S1590-8658(21)00387-X. [PMID: 34393073 DOI: 10.1016/j.dld.2021.07.019] [Reference Citation Analysis]
20 Xiang T, Liang B, Wang H, Quan X, He S, Zhou H, He Y, Yang D, Wang B, Zheng X. Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection. Cell Mol Immunol 2021;18:2679-81. [PMID: 34782756 DOI: 10.1038/s41423-021-00795-5] [Reference Citation Analysis]
21 Spadaccini M, Canziani L, Aghemo A, Lleo A, Maselli R, Anderloni A, Carrara S, Fugazza A, Pellegatta G, Galtieri PA, Hassan C, Greenwald D, Pochapin M, Wallace M, Sharma P, Roesch T, Bhandari P, Emura F, Raju GS, Repici A. What gastroenterologists should know about SARS-CoV 2 vaccine: World Endoscopy Organization perspective. United European Gastroenterol J 2021. [PMID: 34102015 DOI: 10.1002/ueg2.12103] [Reference Citation Analysis]
22 Romagnoli R, Gruttadauria S, Tisone G, Maria Ettorre G, De Carlis L, Martini S, Tandoi F, Trapani S, Saracco M, Luca A, Manzia TM, Visco Comandini U, De Carlis R, Ghisetti V, Cavallo R, Cardillo M, Grossi PA. Liver transplantation from active COVID-19 donors: A lifesaving opportunity worth grasping? Am J Transplant 2021. [PMID: 34467627 DOI: 10.1111/ajt.16823] [Reference Citation Analysis]
23 Cornberg M, Eberhardt CS. Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients. J Hepatol 2021;75:265-6. [PMID: 34048861 DOI: 10.1016/j.jhep.2021.05.007] [Reference Citation Analysis]
24 Moon AM, Webb GJ, García-Juárez I, Kulkarni AV, Adali G, Wong DK, Lusina B, Dalekos GN, Masson S, Shore BM, Barnes E, Barritt AS 4th, Marjot T. SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 Vaccination. Hepatol Commun 2021. [PMID: 34708575 DOI: 10.1002/hep4.1853] [Reference Citation Analysis]
25 Hu X, Sun L, Guo Z, Wu C, Yu X, Li J. Management of COVID-19 Patients with Chronic Liver Diseases and Liver Transplants. Ann Hepatol 2021;:100653. [PMID: 34929350 DOI: 10.1016/j.aohep.2021.100653] [Reference Citation Analysis]
26 Gupta S, Sudhindran S, Saraf N, Vijai A, Swaminathan S, Panackel C, Mehta NN, Varghese J, Singh S, Reddy MS, Viswanathan MS, Bhangui P, Mohanka R, Asthana S, Rohatgi S. Liver Transplant Society of India Guidelines for Liver Transplant during COVID-19 times. J Clin Exp Hepatol 2021. [PMID: 34429571 DOI: 10.1016/j.jceh.2021.08.012] [Reference Citation Analysis]
27 Costantino A, Invernizzi F, Centorrino E, Vecchi M, Lampertico P, Donato MF. COVID-19 Vaccine Acceptance among Liver Transplant Recipients. Vaccines (Basel) 2021;9:1314. [PMID: 34835245 DOI: 10.3390/vaccines9111314] [Reference Citation Analysis]
28 Albariqi AH, Ke WR, Khanal D, Kalfas S, Tang P, Britton WJ, Drago J, Chan HK. Preparation and Characterization of Inhalable Ivermectin Powders as a Potential COVID-19 Therapy. J Aerosol Med Pulm Drug Deliv 2022. [PMID: 35275749 DOI: 10.1089/jamp.2021.0059] [Reference Citation Analysis]
29 Albariqi AH, Wang Y, Yoon Kyung Chang R, Quan DH, Wang X, Kalfas S, Drago J, Britton WJ, Chan HK. Pharmacokinetics and Safety of Inhaled Ivermectin in Mice as a Potential COVID-19 Treatment. Int J Pharm 2022;:121688. [PMID: 35314278 DOI: 10.1016/j.ijpharm.2022.121688] [Reference Citation Analysis]
30 Spearman CW, Aghemo A, Valenti L, Sonderup MW. COVID-19 and the liver: A 2021 update. Liver Int 2021;41:1988-98. [PMID: 34152690 DOI: 10.1111/liv.14984] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Cho JY, Lee YS, Kim SS, Song DS, Lee JH, Kim JH. Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline. Clin Mol Hepatol 2021;27:515-23. [PMID: 34530524 DOI: 10.3350/cmh.2021.0293] [Reference Citation Analysis]
32 Taylor R 3rd, Mallon D. COVID-19 and Pediatric Gastroenterology. Pediatr Clin North Am 2021;68:1157-69. [PMID: 34736582 DOI: 10.1016/j.pcl.2021.07.003] [Reference Citation Analysis]
33 Kayaaslan B, Guner R. COVID-19 and the liver: A brief and core review. World J Hepatol 2021; 13(12): 2013-2023 [DOI: 10.4254/wjh.v13.i12.2013] [Reference Citation Analysis]
34 Fu XL, Chen HL. COVID-19 Vaccine for Chronic Gastroenterology and Hepatology Patients: A Need for Better Evidence. Am J Gastroenterol 2021. [PMID: 34404083 DOI: 10.14309/ajg.0000000000001405] [Reference Citation Analysis]
35 Ma C, Tu D, Gu J, Xu Q, Hou P, Wu H, Guo Z, Bai Y, Zhao X, Li P. The Predictive Value of Myoglobin for COVID-19-Related Adverse Outcomes: A Systematic Review and Meta-Analysis. Front Cardiovasc Med 2021;8:757799. [PMID: 34869669 DOI: 10.3389/fcvm.2021.757799] [Reference Citation Analysis]
36 Negahdaripour M, Shafiekhani M, Moezzi SMI, Amiri S, Rasekh S, Bagheri A, Mosaddeghi P, Vazin A. Administration of COVID-19 vaccines in immunocompromised patients. Int Immunopharmacol 2021;99:108021. [PMID: 34352567 DOI: 10.1016/j.intimp.2021.108021] [Reference Citation Analysis]
37 Krüger M, Robson SC, Schulte Am Esch J. Reply. Clin Gastroenterol Hepatol 2021;19:1510. [PMID: 33727163 DOI: 10.1016/j.cgh.2021.03.018] [Reference Citation Analysis]
38 Alfishawy M, Nso N, Nassar M, Ariyaratnam J, Bhuiyan S, Siddiqui RS, Li M, Chung H, Al Balakosy A, Alqassieh A, Fülöp T, Rizzo V, Daoud A, Soliman KM. Liver transplantation during global COVID-19 pandemic. World J Clin Cases 2021; 9(23): 6608-6623 [PMID: 34447809 DOI: 10.12998/wjcc.v9.i23.6608] [Reference Citation Analysis]
39 Calleri A, Saracco M, Pittaluga F, Cavallo R, Romagnoli R, Martini S. Seroconversion After Coronavirus Disease 2019 Vaccination in Patients Awaiting Liver Transplantation: Fact or Fancy? Liver Transpl 2021. [PMID: 34564945 DOI: 10.1002/lt.26312] [Reference Citation Analysis]
40 Davidov Y, Tsaraf K, Cohen-Ezra O, Likhter M, Ben Yakov G, Levy I, Levin EG, Lustig Y, Mor O, Rahav G, Ben Ari Z. Immunogenicity and Adverse Effect of Two Dose BNT162b2 mRNA Vaccine Among Liver Transplant Recipients. Liver Transpl 2021. [PMID: 34767690 DOI: 10.1002/lt.26366] [Reference Citation Analysis]
41 Omar AS, Kaddoura R, Orabi B, Hanoura S. Impact of COVID-19 pandemic on liver, liver diseases, and liver transplantation programs in intensive care units. World J Hepatol 2021; 13(10): 1215-1233 [PMID: 34786163 DOI: 10.4254/wjh.v13.i10.1215] [Reference Citation Analysis]
42 Eberhardt CS, Balletto E, Cornberg M, Mikulska M. Coronavirus disease 2019 vaccination in transplant recipients. Curr Opin Infect Dis 2021;34:275-87. [PMID: 34074880 DOI: 10.1097/QCO.0000000000000739] [Reference Citation Analysis]
43 Rusk DS, Strachan CC, Hunter BR. Lack of immune response after mRNA vaccination to SARS-CoV-2 in a solid organ transplant patient. J Med Virol 2021;93:5623-5. [PMID: 33913552 DOI: 10.1002/jmv.27044] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Magro F, Nuzzo A, Abreu C, Libânio D, Rodriguez-Lago I, Pawlak K, Hollenbach M, Brouwer WP, Siau K. COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology. United European Gastroenterol J 2021. [PMID: 34190413 DOI: 10.1002/ueg2.12115] [Reference Citation Analysis]
45 Rashidi-Alavijeh J, Frey A, Passenberg M, Korth J, Zmudzinski J, Anastasiou OE, Saner FH, Jahn M, Lange CM, Willuweit K. Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients-A Single-Center Experience. Vaccines (Basel) 2021;9:738. [PMID: 34358154 DOI: 10.3390/vaccines9070738] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Sharma A, Patnaik I, Kumar A, Gupta R. COVID-19 vaccines in patients with chronic liver disease. J Clin Exp Hepatol. 2021;. [PMID: 34177192 DOI: 10.1016/j.jceh.2021.06.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Law MF, Ho R, Law KWT, Cheung CKM. Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases. World J Hepatol 2021; 13(12): 1850-1874 [DOI: 10.4254/wjh.v13.i12.1850] [Reference Citation Analysis]
48 Bakasis A, Bitzogli K, Mouziouras D, Pouliakis A, Roumpoutsou M, Goules AV, Androutsakos T. Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases. Viruses 2022;14:207. [DOI: 10.3390/v14020207] [Reference Citation Analysis]
49 Aguila EJT, Cua IHY, Singh R. Effects of coronavirus disease 2019 on the digestive system and its nutritional implications. Curr Opin Clin Nutr Metab Care 2021;24:440-5. [PMID: 34334686 DOI: 10.1097/MCO.0000000000000785] [Reference Citation Analysis]
50 Hillebrandt K, Nevermann N, Globke B, Moosburner S, Schmelzle M, Pratschke J. [Impact of the COVID-19 pandemic on hepato-pancreato-biliary surgery and organ transplantation]. Chirurg 2021. [PMID: 34297148 DOI: 10.1007/s00104-021-01463-0] [Reference Citation Analysis]
51 Mahmud N, Chapin SE, Kaplan DE, Serper M. Identifying Patients at Highest Risk of Remaining Unvaccinated Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Large Veterans Health Administration Cohort. Liver Transpl 2021. [PMID: 34293247 DOI: 10.1002/lt.26235] [Reference Citation Analysis]
52 Thuluvath PJ, Robarts P, Chauhan M. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases. J Hepatol 2021;75:1434-9. [PMID: 34454993 DOI: 10.1016/j.jhep.2021.08.008] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
53 Gaspar R, Castelo Branco C, Macedo G. Liver and COVID-19: From care of patients with liver diseases to liver injury. World J Hepatol 2021; 13(10): 1367-1377 [PMID: 34786172 DOI: 10.4254/wjh.v13.i10.1367] [Reference Citation Analysis]